Effect of laminar air flow and building construction on aspergillosis in acute leukemia patients: a retrospective cohort study.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
09 Jan 2019
Historique:
received: 28 10 2018
accepted: 28 12 2018
entrez: 11 1 2019
pubmed: 11 1 2019
medline: 6 2 2019
Statut: epublish

Résumé

The preventive effect of laminar air flow (LAF) on aspergillosis has been observed in patients with hematological malignancies. However, the short follow-up period limits the interpretation of study results. To assess the preventive effect of long-term LAF use on aspergillosis in its long-term use, we retrospectively analyzed 124 acute leukemia patients at our hospital between January 2005 and March 2016. We compared the incidence of aspergillosis before (May 2008) and during the construction of a new building (June 2008-January 2010) and in the early (February 2010-March 2014) and late (April 2014-March 2016) periods after moving to a new hematology ward with an LAF system. The 2008 European Organization for Research and Treatment of Cancer and Mycosis Study Group criteria were used for the diagnosis of aspergillosis. Fourteen patients were diagnosed with possible, probable, or definite aspergillosis. Cumulative incidence rates of aspergillosis at day 180 were 12.4, 24.9, 9.3, and 25.1% before construction, during construction, in the early period after moving to a new ward, and in the late period after moving to a new ward, respectively (p = 0.106). Multivariate analysis showed that the LAF system tended to reduce the risk of aspergillosis in the early period (before construction vs. early period; hazards ratio (HR) = 1.97, p = 0.463 and during construction vs. early period;HR = 3.42, p = 0.184), but the risk increased in the late period (late vs. early period, HR = 5.65, p = 0.035). Building construction might increase the risk of aspergillosis. Short-term LAF use might reduce aspergillosis risk, but its long-term use is inadequate, although we could not exclude the possibility of increased risks in the recent period due to continued improvements in the different areas of our hospital. Strict maintenance, more effective LAF system, and optimization of aspergillosis prophylaxis may be necessary.

Sections du résumé

BACKGROUND BACKGROUND
The preventive effect of laminar air flow (LAF) on aspergillosis has been observed in patients with hematological malignancies. However, the short follow-up period limits the interpretation of study results.
METHODS METHODS
To assess the preventive effect of long-term LAF use on aspergillosis in its long-term use, we retrospectively analyzed 124 acute leukemia patients at our hospital between January 2005 and March 2016. We compared the incidence of aspergillosis before (May 2008) and during the construction of a new building (June 2008-January 2010) and in the early (February 2010-March 2014) and late (April 2014-March 2016) periods after moving to a new hematology ward with an LAF system. The 2008 European Organization for Research and Treatment of Cancer and Mycosis Study Group criteria were used for the diagnosis of aspergillosis.
RESULTS RESULTS
Fourteen patients were diagnosed with possible, probable, or definite aspergillosis. Cumulative incidence rates of aspergillosis at day 180 were 12.4, 24.9, 9.3, and 25.1% before construction, during construction, in the early period after moving to a new ward, and in the late period after moving to a new ward, respectively (p = 0.106). Multivariate analysis showed that the LAF system tended to reduce the risk of aspergillosis in the early period (before construction vs. early period; hazards ratio (HR) = 1.97, p = 0.463 and during construction vs. early period;HR = 3.42, p = 0.184), but the risk increased in the late period (late vs. early period, HR = 5.65, p = 0.035).
CONCLUSIONS CONCLUSIONS
Building construction might increase the risk of aspergillosis. Short-term LAF use might reduce aspergillosis risk, but its long-term use is inadequate, although we could not exclude the possibility of increased risks in the recent period due to continued improvements in the different areas of our hospital. Strict maintenance, more effective LAF system, and optimization of aspergillosis prophylaxis may be necessary.

Identifiants

pubmed: 30626352
doi: 10.1186/s12879-018-3665-9
pii: 10.1186/s12879-018-3665-9
pmc: PMC6327489
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38

Références

Am J Hematol. 2001 Apr;66(4):257-62
pubmed: 11279636
Infect Control Hosp Epidemiol. 2002 Jan;23(1):41-3
pubmed: 11868892
MMWR Recomm Rep. 2003 Jun 6;52(RR-10):1-42
pubmed: 12836624
N Engl J Med. 2007 Jan 25;356(4):348-59
pubmed: 17251531
Mycoses. 2008 Mar;51(2):117-22
pubmed: 18254747
Haematologica. 2010 Apr;95(4):644-50
pubmed: 19850903
Bone Marrow Transplant. 2010 Jul;45(7):1220-6
pubmed: 19946343
Haematologica. 2010 Jun;95(6):996-1003
pubmed: 20007135
Blood. 2010 Dec 9;116(24):5111-8
pubmed: 20826719
Clin Infect Dis. 2011 Mar 15;52(6):750-70
pubmed: 21367728
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Haematologica. 2015 Feb;100(2):284-92
pubmed: 25638805
J Hosp Infect. 1989 Aug;14(2):89-94
pubmed: 2572639
J Hosp Infect. 2017 Aug;96(4):336-341
pubmed: 28545828
Eur J Haematol. 2018 Feb;100(2):140-146
pubmed: 29105850
Infection. 1988 Jul-Aug;16(4):199-208
pubmed: 3053457
Am J Med. 1984 May 15;76(5A):42-52
pubmed: 6372478
Bone Marrow Transplant. 1998 Jun;21(12):1231-8
pubmed: 9674857

Auteurs

Makoto Iwasaki (M)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Junya Kanda (J)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Masakatsu Hishizawa (M)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Toshiyuki Kitano (T)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Tadakazu Kondo (T)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. tadakazu@kuhp.kyoto-u.ac.jp.

Kouhei Yamashita (K)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Akifumi Takaori-Kondo (A)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH